Emory University

Incremental prognostic value of coronary computed tomography angiography over coronary calcium scoring for major adverse cardiac events in elderly asymptomatic individuals (2018) Han D, Hartaigh BO, Gransar H, Lee JH, Rizvi A, Baskaran L, Schulman-Marcus J, et al. Journal article Influence of symptom typicality for predicting MACE in patients without obstructive coronary artery disease: From the CONFIRM Registry (Coronary Computed Tomography Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) (2018) Lee JH, Han D, Hartaigh BO, Gransar H, Lu Y, Rizvi A, Park MW, et al. Journal article The SAMHD1-mediated block of LINE-1 retroelements is regulated by phosphorylation (2018) Herrmann A, Wittmann S, Thomas D, Shepard CN, Kim B, Ferreiros N, Gramberg T Journal article Safety and Efficacy of a 3-Dimensional Stent Retriever With Aspiration-Based Thrombectomy vs Aspiration-Based Thrombectomy Alone in Acute Ischemic Stroke Intervention: A Randomized Clinical Trial (2018) Nogueira RG, Frei D, Kirmani JF, Zaidat O, Lopes D, Turk AS, Heck D, et al. Journal article MAGIC biomarkers predict long term outcomes for steroid-resistant acute GVHD (2018) Major-Monfried H, Renteria AS, Pawarode A, Reddy P, Ayuk F, Holler E, Efebera YA, et al. Journal article The Coronary Artery Disease-Reporting and Data System (CAD-RADS): Prognostic and Clinical Implications Associated With Standardized Coronary Computed Tomography Angiography Reporting (2018) Xie JX, Cury RC, Leipsic J, Crim MT, Berman DS, Gransar H, Budoff MJ, et al. Journal article Highlights of the Twelfth Annual Scientific Meeting of the Society of Cardiovascular Computed Tomography (2018) Weir-Mccall JR, Villines TC, Shaw LJ, Abbara S, Ferencik M, Nieman K, Achenbach S, Nicol E Journal article, Report Commonalities in epileptogenic processes from different acute brain insults: Do they translate? (2018) Klein P, Dingledine R, Aronica E, Bernard C, Blümcke I, Boison D, Brodie MJ, et al. Journal article Treatment-free interval as a metric of patient experience and a health outcome of value for advanced multiple myeloma: the case for the histone deacetylase inhibitor panobinostat, a next-generation novel agent (2017) Richardson P, Roy A, Acharyya S, Panneerselvam A, Mendelson E, Guenther A, Lonial S, Einsele H Journal article Panobinostat plus bortezomib and dexamethasone: impact of dose intensity and administration frequency on safety in the PANORAMA 1 trial (2017) San-Miguel JF, Hungria VTM, Yoon SS, Beksac M, Dimopoulos MA, Elghandour A, Jedrzejczak WW, et al. Journal article